KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Total Current Liabilities (2020 - 2025)

Oscar Health's Total Current Liabilities history spans 6 years, with the latest figure at $4.9 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 40.41% year-over-year to $4.9 billion; the TTM value through Dec 2025 reached $4.9 billion, up 40.41%, while the annual FY2025 figure was $4.9 billion, 40.41% up from the prior year.
  • Total Current Liabilities reached $4.9 billion in Q4 2025 per OSCR's latest filing, up from $4.0 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $4.9 billion in Q2 2025 to a low of $1.6 billion in Q3 2021.
  • Average Total Current Liabilities over 5 years is $3.0 billion, with a median of $3.1 billion recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: soared 76.45% in 2022, then decreased 27.75% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $1.9 billion in 2021, then surged by 76.21% to $3.3 billion in 2022, then fell by 25.58% to $2.4 billion in 2023, then soared by 42.58% to $3.5 billion in 2024, then skyrocketed by 40.41% to $4.9 billion in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Total Current Liabilities are $4.9 billion (Q4 2025), $4.0 billion (Q3 2025), and $4.9 billion (Q2 2025).